RLAY
Relay Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Relay Therapeutics (RLAY) Stock: Buy, Sell, or Hold?
$19.94
-0.45 (-2.21%)
▼
5d:
+14.33%
30d:
+10.9%
90d:
-0.65%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$17.25 – $19.18
Position: EXTENDED
Forward P/E & Valuation
-12.7x
Next 12M consensus est.
Wall Street Target
$28.25
+41.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$16.52 / $20.96
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: RLAY shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When RLAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RLAY is currently trading at $19.94, which is considered extended relative to its 30-day fair value range of $17.25 to $19.18.
Technical Outlook: Technically, RLAY is in a downtrend. Immediate support is located at $16.52, while resistance sits at $20.96.
Market Sentiment: RLAY scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.25 (+41.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RLAY is in a downtrend. Immediate support is located at $16.52, while resistance sits at $20.96.
Market Sentiment: RLAY scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.25 (+41.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.25 -
$19.18
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
Trading Range & Key Levels
30-Day Trading Range
$17.25 -
$19.18
Current vs Trading Range
EXTENDED
Support Level
$16.52
Resistance Level
$20.96
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.7% below Wall St target ($28.25)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.65
Wall Street Target
$28.25
(+41.7%)
Revenue Growth (YoY)
-48.3%
Share RLAY Analysis
Share this live RLAY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RLAY)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 19, 2026
Daily AI digest
AI Retail Discussion Summary:
Investor optimism on $RLAY grows as lead drug zovegalisib advances in Phase 3 trials for PIK3CA-mutated breast cancer and vascular anomalies, offering a potential second approval.
Key Retail Themes:
Clinical trial progress
Potential for multiple approvals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
Data refreshes hourly during market hours. Next update: 9:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RLAY Research Pages
